MARINO MERLO, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 4.298
EU - Europa 3.033
AS - Asia 2.215
SA - Sud America 844
AF - Africa 59
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.460
Nazione #
US - Stati Uniti d'America 4.229
SG - Singapore 945
BR - Brasile 744
IE - Irlanda 683
CN - Cina 633
SE - Svezia 591
IT - Italia 380
RU - Federazione Russa 363
HK - Hong Kong 273
DE - Germania 230
UA - Ucraina 183
FI - Finlandia 145
PL - Polonia 131
VN - Vietnam 121
FR - Francia 120
GB - Regno Unito 82
IN - India 62
CA - Canada 35
AR - Argentina 34
ID - Indonesia 24
CZ - Repubblica Ceca 23
MX - Messico 23
EC - Ecuador 21
JP - Giappone 20
BE - Belgio 18
AT - Austria 17
BD - Bangladesh 17
MA - Marocco 17
UZ - Uzbekistan 17
NL - Olanda 16
ZA - Sudafrica 16
TR - Turchia 15
IQ - Iraq 13
CO - Colombia 11
ES - Italia 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
IR - Iran 8
JO - Giordania 7
LT - Lituania 7
PK - Pakistan 7
VE - Venezuela 7
PY - Paraguay 6
TN - Tunisia 6
EG - Egitto 5
KE - Kenya 5
KZ - Kazakistan 5
PA - Panama 5
CH - Svizzera 4
CL - Cile 4
IL - Israele 4
KR - Corea 4
NZ - Nuova Zelanda 4
PE - Perù 4
AU - Australia 3
BO - Bolivia 3
BY - Bielorussia 3
DZ - Algeria 3
EU - Europa 3
OM - Oman 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IM - Isola di Man 2
JM - Giamaica 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
QA - Qatar 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 10.459
Città #
Dublin 683
Dallas 682
Ashburn 542
Chandler 519
Singapore 471
Nyköping 414
Jacksonville 376
Beijing 299
Hong Kong 273
Los Angeles 141
Warsaw 127
The Dalles 119
Messina 107
Princeton 106
Medford 97
Cambridge 95
Ann Arbor 91
Moscow 90
Munich 85
Des Moines 75
Dearborn 74
New York 63
Boardman 60
São Paulo 55
Buffalo 52
Turku 38
Jinan 35
San Mateo 35
Wilmington 35
Redondo Beach 31
Ho Chi Minh City 30
Woodbridge 30
Rio de Janeiro 29
Tianjin 29
Shenyang 23
Hanoi 22
Nanjing 21
Tokyo 20
Brussels 18
Pune 18
Stockholm 18
Houston 17
Tashkent 17
Brasília 16
Dong Ket 16
Helsinki 16
Montreal 16
Rome 15
Ningbo 14
Olomouc 14
Seattle 14
Brooklyn 13
Francofonte 13
Jakarta 13
Zhengzhou 13
Chennai 12
London 12
San Francisco 12
Santa Clara 12
Vienna 12
Washington 12
Amsterdam 11
Boston 11
Catania 11
Frankfurt am Main 11
Hangzhou 11
Milan 11
Nanchang 11
Poplar 11
Belo Horizonte 10
Chicago 10
Johannesburg 10
Atlanta 9
Augusta 9
Baku 9
Hyderabad 9
Quito 9
Ribeirão Preto 9
Düsseldorf 8
Falls Church 8
Fortaleza 8
Haikou 8
Joinville 8
Lauterbourg 8
Manaus 8
Montevideo 8
Mumbai 8
Napoli 8
Porto Alegre 8
Amman 7
Ankara 7
Changsha 7
Curitiba 7
Guangzhou 7
Leawood 7
Mexico City 7
Norwalk 7
São José dos Campos 7
Turin 7
Ardabil 6
Totale 6.743
Nome #
Studio di nuove formulazioni di rivestimenti protettivi per imbarcazioni con proprietà antivegetative 215
Molecular surveillance of healthcare-associated Candida infections in a rehabilitation center for patients with severe acquired brain injuries 172
Effetto della presenza di nanotubi di carbonio sulle proprietà meccaniche, fisiche e biologiche di nanocompositi a base di resina poliestere 168
Amphiphilic cyclodextrins as capping agents for gold colloids: A spectroscopic investigation with perspectives in photothermal therapy 161
A novel, rapid assay for evaluating the inhibitory activity of new compounds towards HTLV-1 reverse transcriptase activity. 156
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 143
Ruolo della proteina virale vhs nel controllo della risposta innata cellulare mediata da PKR durante l’infezione da HSV-1. 142
HSV-1-induced activation of NF-κB protects U937 monocytic cells against both virus replication and apoptosis 141
L’aumento della resa virale e dell’apoptosi in cellule monocitiche infettate da HSV-1 a seguito di inibizione di NF-kB non dipende dalla regolazione trascrizionale di TNF-α o IFN 139
Activation of NF-KB in the very-early phase of HSV-1 infection: role of glycoprotein D/HveA interaction 137
Role of NF-kappa B transcription factor in innate response to HSV-1 infection of monocytic U937 cells 133
Multilocus sequence typing reveals a new cluster of closely related Candida tropicalis genotypes in Italian patients with neurological disorders 133
Anti-herpes simplex virus 1 and immunomodulatory activities of a poly-g- glutamic acid from Bacillus horneckiae strain APA of shallow vent origin 132
Il fattore di trascrizione nucleare kappa b gioca un ruolo nell’immunità innata nei confronti dell’ infezione da HSV-1 in cellule monocitiche U937. 131
Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD 125
Engagement of HSV-1 gD with HVEM cellular receptor induces NF-kB activation. 124
Knockdown of Bcl-2 by siRNA abolishes the permissiveness state of HeLa cells to HSV-2 infection. 123
Signaling activity by herpes simplex virus: molecular mechanisms and biotechnological implications 123
Apoptosi e Virus. 123
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s disease. 123
Coinvolgimento del recettore HVEM nell'attivazione di NF-kB da parte della glicoproteina D di HSV-1 121
Forced expression of HveA renders cells sensitive to NF-kB activation by UV-inactivated HSV-1 or HSV-1 glycoprotein D. 121
A novel, PCR-based for evaluating the HIV-RT inhibitory activity of antiretroviral compounds 121
Inhibition of NF-kappaB activation enhances HSV-1 replication in U937 cells 120
AZT treatment potentiates apoptosis induction by NF-kB inhibitors in HTLV-1 infected cells 120
Bcl-2 overexpression overcomes the incapability of monocytoid cells to sustain a fully-productive infection by HSV-2. 119
STUDI SUL RUOLO DI NF-KAPPA B E DELL’APOPTOSI NELL’ INFEZIONE DI CELLULE U937 DA PARTE DI HSV-1. 119
Ruolo dell'interazione glicoproteina D/recettore HVEA nell'attivazione precoce di NF-kB da parte di HSV-1. 118
La risposta innata nelle infezioni virali: ruolo del fattore nucleare kappa B. 117
A novel, rapid assay for evaluating the inhibitory activity of new compounds towards HTLV-1 reverse transcriptase activity 114
HVEM-mediated activationof nuclear factor kB by HSV-1 glycoprotein D. 114
Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α 113
NF-ΚB-dependent production of ROS and restriction of HSV-1 infection in U937 monocytic cells 113
L'over-espressione del protooncogene bcl-2 rende le cellule monocitoidi U937 pienamente permissive all'infezione da HSV-2. 112
Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSVA gD. 111
Herpes simplex virus and cell apoptotic response 111
Key role of Bcl-2 expression for productive HSV-2 replication. 110
L’ ATTIVAZIONE DI NF-KAPPA B E’ ASSOCIATA ALLA PARZIALE RESTRIZIONE DELL’ INFEZIONE DA HSV-1 IN CELLULE U937. 110
Il silenziamento del protooncogene Bcl-2 mediante siRNA rende le cellule HeLa non permissive all'infezione da HSV-2. 109
Role of herpesvirus entry Receptor A in replication-indipendent NF-kB activation by HSV-1. 109
Genetic diversity of Candida albicans isolates recovered from hospital environments and patients with severe acquired brain injuries 109
Involvement of HVEM receptor in activation of nuclear factor KB by HSV-1 glycoprotein D. 108
Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol 106
Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview 106
Expression of genes encoding innate antiviral response in human monocytic cells, transfected or not with a dominant negative NF-kappa-B, following HSV-1 infection . 105
Future perspectives on drug targeting in adult T cell leukemia-lymphoma 104
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells 103
Development and evaluation of a simple and effective RT-qPCR inhibitory assay for detection of the efficacy of compounds towards HIV reverse transcriptase 103
Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors 102
Appraisal of a simple and effective RT-qPCR assay for evaluating the reverse transcriptase activity in blood samples from HIV-1 patients 101
Signaling pathway utilized by HSV-1 to induce NF-kB activation: possible role of herpesvirus entry receptor A. 100
Signaling cellulare ed infezione da virus herpes simplex. 100
Role of Caspase-8 in HSV-1 induced cell death 96
Antioxidant Activity of a Sicilian Almond Skin Extract Using In Vitro and In Vivo Models 95
Apoptosis induced by HSV-1 requires BH3-only protein Puma and p73. 95
Caspase-8 is required for HSV-1-induced apoptosis and promotes effective viral particle release via autophagy inhibition 94
Inhibition of NF-kB activation sensitizes U937 cells to 3’-azido-3’-deoxythymidine (AZT) induced apoptosis 94
D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent 93
Testing anti-HIV activity of antiretroviral agents in vitro using infection of CEM-GFP cells with an HIV-1 NL4-3 recombinant strain and flow cytometry. 92
NF-kB-dependent Protection From Apoptosis by HSV-1 gD/HVEM Interaction. 91
Inhibition of NF-kB activation sensitizes U937 cells to 3’-azido-3’-deoxythymidine (AZT) induced apoptosis 90
A novel, cell-free PCR-based assay for evaluating the inhibitory activity of antiretroviral compounds against HIV reverse transcriptase. 89
Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells 89
Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB 89
Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy 88
Binding of herpes simplex virus 1 to HVEM receptor through envelope glycoprotein D ensures protection against apoptosis. 88
Signaling Pathway Utilized by HSV-1 to Induce NF-kB Activation: Possible Role of Herpesvirus Entry Receptor A. 88
Polyester Resin and Carbon Nanotubes Based Nanocomposite as New Generation Coating to Prevent Biofilm Formation 85
Truncated phosphonated C-1'-branched N,O-nucleosides: A new class of antiviral agents. 84
Modulazione dell’attivazione di nf-kb da parte di 3’-azido-3’ deossitimidina (AZT): possibili implicazioni terapeutiche 83
Lysosomal membrane permeabilization is involved in apoptosis induced by HSV-1 in monocytic cells 83
Excited triplet state behaviour , singlet oxygen photogeneration and photodynamic cellular damage of porphyrin embedded in cationic cyclodextrin vescicles. 81
Sherris Microbiologia Medica 81
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3 81
N,O-Nucleoside Analogues: Metabolic and Apoptotic Activity 81
Synthesis and biological testing of thioalkane- and thioarene-spaced bis-beta-D-glucopyranosides 80
Ruolo dell'espressione di Bcl-2 sullo stato di permissivita' cellulare all'infezione da HSV-2 in vitro 78
Synthesis and biological evaluation of a new class of glycoconjugated disulfides that exhibit potential anticancer properties 78
Antiviral innate response in HSV-1 infected monocytic cells 78
Nanoparticles of Cationic Amphiphilic Cyclodextrins entangling anionic porphyrins: a promising non-covalent “carrier/sensitizer” system in photodynamic cancer therapy 75
Role of the Bh3-only protein Puma and p73 in apoptosis induced by herpes simplex virus 1 75
Synthesis and biological evaluation of styrylheterocycles analogs of resveratrol as apoptosis-inducing agents 74
Evaluation of the capability of antiviral compounds to inhibit retroviral reverse transcriptase by means of a novel assay 73
Phosphonated Nucleoside Analogues as Antiviral Agents 70
Wilde type gD of HSV-1, but not a mutated form incapable of binding HveA receptor, activates NF-kB in monocytoid cells. 68
Determinazione della efficacia di composti di inibire la Trascrittasi Inversa di HIV mediante un nuovo saggio basato sulla reazione di PCR 68
Involvement of NF-kB activation in tipping the balance in favor of survival or apoptosis in 3’-azido-3’-deoxythymidine (AZT) treated cells 66
Synthesis and biological evaluation of novel small non-peptidic HIV-1 PIs: the benzothiophene ring as an effective moiety. 65
Determination of sensitivity of HIV reverse transcriptase to inhibitory compounds by a new, cell free, PCR-based assay 65
Vie di segnale a valle del recettore HveA utilizzate da HSV-1 per indurre l'attivazione di NF-kB. 63
Functional NF-kappa B signaling restricts both virus replication and apoptosis in monocytic cells infected by HSV-1 63
Se-(2-aminoalkyl)selenocysteines as biochemical redox agents. A tool to contrast cell injury induced by aflatoxin B1 in HepG2 cells 62
Effect of efavirenz and nevirapine on HIV reverse transcriptase activity through a novel, PCR-based assay. 62
Truncated Phosphonated C-1’-Branched N,O-Nucleosides: a new class of antiretroviral agents 61
Installing tungsten Fischer carbene complexes into a calixarene framework 60
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 59
Mechanisms involved in D(-) lentiginosine-induced apoptosis 58
Mixed nanoaggregates of cationic and galactosylated amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer systems for targeted PDT. 56
L’inibizione dell’attivazione di NF-kB potenzia l’azione pro-apoptotica della 3’-azido-3’-deossitimidina (AZT). 55
Se-(2-aminoalkyl)selenocysteines as biochemical redox agents. A tool to contrast cell injury induced by aflatoxin B1 in HepG2 cells 55
Totale 10.090
Categoria #
all - tutte 37.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 0 0 88 37 59 60 88 75 34
2021/2022648 12 50 20 27 32 9 44 31 10 30 159 224
2022/20232.021 150 244 83 162 125 195 33 122 822 14 47 24
2023/2024523 46 69 27 36 56 123 13 50 9 36 3 55
2024/20252.209 33 54 60 142 73 77 22 476 570 131 230 341
2025/20263.051 383 434 734 487 618 395 0 0 0 0 0 0
Totale 10.599